Circulating tumour DNA as a predictive biomarker for tumour response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer
Introduction: Immune checkpoint inhibitors (ICIs) have revolutionised the treatment of advanced non-small cell lung cancer (NSCLC). Quantitative monitoring of disease burden may prove predictive in these cases. We hypothesised that serial ctDNA molecular response assessment may be predictive of resp...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2025-11-01
|
| Col·lecció: | Lung India |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.4103/lungindia.lungindia_127_25 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|